CUBE vs FOLD
CubeSmart (CUBE) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the CUBE and FOLD stock pages for the full models.
Not investment advice.